Skip to content

Clinical trials

Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Country / region: South Korea Clear all

404 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20062
200710
200810
20098
201021
201119
201218
201317
201429
201522
201614
201719
201830
201935
202025
202122
202221
202325
202421
202521
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed193
Active, not recruiting65
Recruiting63
Terminated51
Unknown status28
Enrolling by invitation2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie35
GlaxoSmithKline24
AstraZeneca20
Novartis Pharmaceuticals20
Hoffmann-La Roche15
Samsung Medical Center14
Pfizer13
Seoul National University Hospital13
Bayer12
Merck Sharp & Dohme LLC11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms404
Carcinoma, Non-Small-Cell Lung76
Neoplasm Metastasis46
Breast Neoplasms36
Colorectal Neoplasms33
Lung Neoplasms30
Neoplasms by Site29
Stomach Neoplasms27
Adenocarcinoma19
Carcinoma18

Trials

Showing 51 to 75 of 404. Each trial links to its page on Pharma Observatory.

304 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.